Forte Biosciences Inc (FBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,363 | 24,498 | 30,444 | 37,125 | 46,185 |
| TOTAL | $17,668 | $25,711 | $31,502 | $38,327 | $47,102 |
| Non-Current Assets | |||||
| PPE Net | 86 | 96 | 106 | 109 | 98 |
| Other Non-Current Assets | 192 | 271 | 409 | 544 | 679 |
| TOTAL | $278 | $367 | $515 | $653 | $777 |
| Total Assets | $17,946 | $26,078 | $32,017 | $38,980 | $47,879 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,159 | 5,275 | 1,685 | 1,424 | 5,354 |
| Accrued Expenses | 3,421 | 3,842 | 1,647 | 2,242 | 2,117 |
| TOTAL | $8,580 | $9,117 | $3,332 | $3,666 | $7,471 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $8,580 | $9,117 | $3,332 | $3,666 | $7,471 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,462 | N/A | 1,458 | 1,456 | 1,453 |
| Common Shares | 1 | 36 | 36 | 1 | 36 |
| Retained earnings | -146,843 | -138,451 | -125,940 | -118,520 | -112,648 |
| Other shareholders' equity | 1 | -7 | -2 | 4 | -5 |
| TOTAL | $9,366 | $16,961 | $28,685 | $35,314 | $40,408 |
| Total Liabilities And Equity | $17,946 | $26,078 | $32,017 | $38,980 | $47,879 |